Self-administered symptom questionnaires in patients with dyspepsia and their yield in discriminating between endoscopic diagnoses

Digestive Diseases

Volumn 20, Issue 2, 2002, Pages 191-198

  Bolling Sternevald, Elisabeth ^a,b   Carlsson, R ^b   Aalykke, C ^c   Wilson, B V L ^c   Junghard, O ^b   Glise, H ^a   Lauritsen, K ^c  

^a Linkoping Hospital   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Barrett's oesophagus; Duodenal ulcers; Dyspepsia, endoscopic diagnoses; Functional dyspepsia; Gastric neoplasm; Gastric ulcers; Gastro oesophageal reflux disease; General well being; Non ulcer dyspepsia; Oesophagitis; Peptic ulcer disease; Quality of life

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER DIAGNOSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFECATION DISORDER; DIAGNOSTIC PROCEDURE; DUODENITIS; DUODENUM ULCER; DYSPEPSIA; ESOPHAGITIS; FEMALE; GASTRITIS; GASTROINTESTINAL SYMPTOM; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; STOMACH ACID; STOMACH CARCINOMA; SURGICAL TECHNIQUE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; DUODENITIS; DYSPEPSIA; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL DISEASES; ESOPHAGEAL NEOPLASMS; ESOPHAGITIS; ESOPHAGOSCOPY; FEMALE; GASTRITIS; GASTROINTESTINAL DISEASES; GASTROINTESTINAL NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PEPTIC ULCER; QUESTIONNAIRES;

EID: 12244256086     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000067482     Document Type: Article

References (30)

1. Jones R, Lydeard S: Prevalence of symptoms of dyspepsia in the community. BMJ 1989;298:30-32.
2. Brown C, Rees WDW: Dyspepsia in general practice. BMJ 1990;300:829-830.
3. Knill-Jones RP: Geographical differences in the prevalence of dyspepsia. Scand J Gastroenterol 1991;26:17-24.
4. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ: Dyspepsia and dyspepsia subgroups: A population-based study. Gastroenterology 1992;102:1259-1268.
5. Drossman DA, Li Z, Andruzzi E, et al: U.S. householder survey of functional gastrointestinal disorders: Prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38:1569-1580.
6. Agreus L, Svardsudd K, Nyren O, Tibblin G: The epidemiology of abdominal symptoms: Prevalence and demographic characteristics in a Swedish adult population. A report from the Abdominal Symptom Study. Scand J Gastroenterol 1994;29:102-109.
7. Agreus L, Svardsudd K, Nyrén O, Tibblin G: Irritable bowel syndrome and dyspepsia in the general population: Overlap and lack of stability over time. Gastroenterology 1995;109:671-680.
8. Agreus L: Socio-economic factors, health care consumption and rating of abdominal symptom severity. A report from the Abdominal Symptom Study. Fam Pract 1993;10:152-163.
9. Agreus L: Natural history of gastroesophageal reflux disease and functional abdominal disorders: A population-based study. Am J Gastroenterol 2001;96:2905-2914.
10. Talley NJ, Silverstein MD, Agreus L, Nyrén O, Sonnenberg A, Holtmann G: Evaluation of dyspepsia. Gastroenterology 1998;114:582-595.
11. Talley NJ, Colin-Jones D, Kock KL, Kock M, Nyrén O, Stanghellini V: Functional dyspepsia: A classification with guidelines for diagnosis and management. Gastroenterol Int 1991;4:145-160.
12. Jones RH, Lydeard SE, Hobbs FD, Kenkre JE, Williams EI, Jones SJ, Repper JA, Caldow JL, Dunwoodie WM, Bottomley JM: Dyspepsia in England and Scotland. Gut 1990;31:401-405.
13. Castell DO, Holtz A: Gastroesophageal reflux: Don't forget to ask about heartburn. Postgrad Med 1989;86:141-148.
14. Bytzer P: Predicting endoscopic diagnosis in the dyspeptic patient. Scand J Gastroenterol 1997;32:118-125.
15. Lydeard S, Jones R: Factors affecting the decision to consult with dyspepsia: Comparison of consulters and non-consulters. J R Coll Gen Pract 1989;39:495-498.
16. Holtmann GE, Goebell H, Talley NJ: Dyspepsia in consulters and non-consulters: Prevalence, health-care seeking behaviour and risk factors. Eur J Gastroenterol Hepatol 1994;6:917-924.
17. Johannessen T, Petersen H, Kleveland PM, Dybdahl JH, Sandvik AK, Brenna E, Waldum H: The predictive value of history in dyspepsia. Scand J Gastroenterol 1990;25:689-697.
18. Kennedy TM, Jones RH, Hungin AP, O'Flanagan H, Kelly P: Irritable bowel syndrome, gastroesophageal reflux, and bronchial hyperresponsiveness in the general population. Gut 1998;43:770-774.
19. Howell S, Talley NJ: Does fear of serious disease predict consulting behaviour amongst patients with dyspepsia in general practice? Eur J Gastroenterol Hepatol 1999;11:881-886.
20. Tougas G, Chen Y, Hwang P, Liu MM, Eggleston A: Prevalence and impact of upper gastrointestinal symptoms in the Canadian population: Findings from the DIGEST Study. Domestic/International Gastroenterology Surveillance Study. Am J Gastroenterol 1999;94:2845-2854.
21. Moayyedi P, Braunholtz D, Atha P, et al: The influence of dyspepsia,Helicobacter pyloristatus and irritable bowel syndrome on quality of life in the community (abstract). Gastroenterology 1998;114:231.
22. Dimenäs E, Glise H, Hallerbäck B, Hernqvist H, Svedlund J, Wiklund I: Quality of life in patients with upper gastrointestinal symptoms. Scand J Gastroenterol 1993;28:681-687.
23. Dimenäs E, Glise H, Hallerback B, Hernqvist H, Svedlund J, Wiklund I: Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 1995;30:1046-1052.
24. Carlsson R, Dent J, Bolling-Sternevald E, Johnsson F, Junghard O, Lauritsen K, Riley S, Lundell L: The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol 1998;33:1023-1029.
25. Dupuy HJ: Psychological General Well-Being (PGWB) index; in Wenger NK, Mattson ME, Furberg CF, Elinson J: Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York, Le Jacq, 1984, pp 170-183.
26. Glise H, Wiklund I: Health-related quality of life and gastrointestinal disease. J Gastroenterol Hepatol 2002;17(suppl):73-85.
27. Sandmark S, Carlsson R, Fausa O, Lundell L: Omeprazole or ranitidine in the treatment of reflux esophagitis: Results of a double-blind, randomized, Scandinavian multicenter study. Scand J Gastroenterol 1988;23:625-632.
28. Stanghellini V, Tosetti C, Paternico A, De Giorgio R, Barbara G, Salvioli B, Corinaldesi R: Predominant symptoms identify different subgroups in functional dyspepsia. Am J Gastroenterol 1999;94:2080-2085.
29. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN: Functional gastroduodenal disorders. Gut 1999;45:37-42.
30. Thomson AB, Armstrong D, Barkun A, et al: The high prevalence of clinically significant findings (CSFs) at endoscopy (EGD) in patients with uninvestigated dyspepsia (UD) is not predicted by patients' dyspepsia symptoms (Cadet-PE study). Can J Gastroenterol 2002;16:A149.